Stay Informed

WNDM Medical Inc.

With our focus on improving patient outcomes with evidenced-based healing solutions, WNDM Medical Inc. develops, markets and distributes biotechnology products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce more efficacious outcomes at a lower overall cost. Our primary products are sold in the North American advanced wound care and surgical tissue repair markets. WNDM Medical sells and distributes CellerateRX® Surgical Activated Collagen® Adjuvant and HemaQuell® Resorbable Bone Hemostat.


Innovation isn't born. It's bred. That’s why our approach to product development merges science and technology with the goal of creating innovative, safe and cost-effective products for the ever-changing surgery landscape.

Valid in most surgical specialties, our products are cost-effective across the continuum of care. They are supported by our growing internal sales management team and a network of seasoned health care distributors.




logo CellerateRX Surgical3

CellerateRX® Surgical is changing collagen’s role in the operating room across specialties where comorbidities and postoperative incisional healing risks are a concern. Find out how CellerateRX® Surgical provides a favorable environment for healing and can help high-risk patients.



WNDM Medical Inc., is an emerging commercial stage company with its primary products in the $11 billion U.S. consumable medical device market and in the $1.5 billion biomaterials market. Our primary focus is the distribution of our unique, patented CellerateRX® Surgical Activated Collagen® Adjuvant, which is FDA-cleared and indicated for all surgical and traumatic wounds, except third degree burns. We have also received FDA-clearance for HemaQuell® Resorbable Bone Hemostat.

WNDM Medical Inc.’s Code of Ethics

Contact Us

Contact Form


WNDM Medical Inc.

1200 Summit Avenue
Suite 414
Fort Worth, TX

Phone: 817-529-2300